Physician profile
Deval U Patel
NPI 1477768513
$730.98
in general payments reported to CMS, 2019-2025
12 companies · $137 in 2025
The $137 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.69 · 2020: $17.62 · 2021: $249 · 2022: $171 · 2023: $17.92 · 2024: $120 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $142.68 | 2022 | |
| Stryker Corporation | $137.45 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Gilead Sciences, INC. | $119.57 | 2024 | |
| Horizon Therapeutics Plc | $96.29 | 2021 | |
| Janssen Pharmaceuticals, INC | $72.81 | 2021 | |
| Biofire Diagnostics, LLC | $40.00 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $35.61 | 2019-2023 | Andexxa |
| Abbvie INC. | $28.05 | 2021 | |
| Csl Behring | $17.62 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $16.56 | 2022 | |
| Melinta Therapeutics, LLC | $12.23 | 2022 | |
| Medtronic, INC. | $12.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deval Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.